A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer (Q27851690)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer |
scientific article |
Statements
1 reference
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer (English)
1 reference
18 October 2012
0 references
31
0 references
42
0 references
4559-66
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference